ABCG2 and lung carcinoma: These results are in line with previous reports of nuclear ABCG2 shuttling in lung cancer resulting in reduced cell migration and increased differentiation [65, 66], with consequently a decreased ABC transporter efflux activity at the cell membrane expected to reduce drug resistance [67].